Are ethnopharmacological surveys useful for the discovery and development of drugs from medicinal plants?  by Albuquerque, Ulysses Paulino et al.
* Corresponding author. 
 E-mail:  upa@db.ufrpe.br (U.P. Albuquerque).




Received 15 November 2013






A B S T R A C T
Ethnopharmacological and ethnobotanical approaches are described in the literature 
as efficient to identify plants of interest for phytochemical and pharmacological 
studies. In the present work, we reflect on the quality of the data collected in ethno-
directed studies. In accordance to the problems identified in published studies, and 
their theoretical and methodological underpinnings, we believe that these studies are 
poorly suited to contribute to the advancement of research aimed at the development 
of novel drugs. 
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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Introduction 
Despite the richness of the ethnopharmacological surveys 
performed worldwide, and the increase in knowledge of the 
use of natural resources by local communities (Albuquerque et 
al., 2012), particularly in Brazil, many of the collected data were 
found not to be sufficiently sound for bioprospecting purposes. 
In fact, the ethnopharmacological/ethnobotanical approach 
has been progressively losing its appeal as a tool for systematic 
identification of novel pharmaceutical drugs because this 
approach has failed to locate new species that could represent 
interesting candidates for further phytochemical and 
pharmacological studies (Gertsch, 2009). The reasons for this 
failure include the poor quality of many studies (Albuquerque 
and Hanazaki, 2006; 2009) both from a pharmacological point 
of view and in the data collection of ethnopharmacological 
surveys. From the pharmacological side, many of the problems 
are associated with limitations in the methods employed and 
misinterpretations of the bioassay results (Houghton et al., 
2007; Gertsch, 2009). Nevertheless, in order to characterize the 
scenario we have to consider the affirmation of Gertsch (2009), 
which states that: 
 “(…) in the last 20 years few significant discoveries have been 
made. This may in part be based on the fact that the many of most 
relevant plant constituents, including the psychoactive, poisonous, 
and antitumor natural products, have already been found and we 
have to work harder to find yet another molecule that will change 
the world”.
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In ethnopharmacological surveys, the problems include 
inadequate design for data collection, and the misinterpretation 
of the role medicinal plants play in the medical systems of 
local and indigenous communities (Etkin, 1993; Moerman, 
2007; Albuquerque and Hanazaki, 2006; 2009). For instance, 
our current database relative to the local uses of the 
Brazilian medicinal flora is quite large, but it exhibits various 
methodological biases that limit our power of interpretation, 
as shown by Medeiros et al. (2013a,b). Furthermore, other 
authors have mentioned the fragility of taxonomic information 
for the species studied in ethnopharmacological studies 
(Bennett and Balick, 2014; Rivera et al., 2014). Considering the 
problems mentioned, the present manuscript focuses on issues 
associated with ethnobotanical/ethnopharmacological data 
collection of medicinal plants, a topic that has been neglected 
in the ethnopharmacological literature (Etkin, 1993; Reyes-
García, 2010). 
One should bear in mind that not all records resulting from 
ethnopharmacological surveys of medicinal plants can be 
validated from the medical point of view for several reasons: 
1. Data collection does not take into consideration the full 
scope of the particularities of the local medical systems; 2. 
Records include a maladaptive culture trait (i.e., therapeutic 
indications that do not seem to be biologically effective); 
and 3. Records include traits exclusively adapted to the 
studied population. Therefore, to promote a debate on the 
ethnopharmacological/ethnobotanical approach with respect 
to bioprospecting, henceforth designated as ethnodirected, the 
present article discusses the main weak points of this approach 
and possible alternatives to overcome its limitations, based 
on experiences from our research group. The topics discussed 
here include sampling issues, the selection of plants relevant 
for bioprospecting based on their popularity and versatility, 
and the omission of information indispensable for efficiently 
testing the plants. 
In this manuscript we are do not consider that 
bioprospecting and ethnopharmacology have the same 
meaning, but rather we are critically reflecting on the direction 
commonly adopted by ethnopharmacological studies that seek 
to increase knowledge for the discovery of new drugs from 
natural products. The following considerations aim to lead to 
a reflection on the tools that are currently used by researchers 
who explicitly aim to collaborate on the above-mentioned 
issues.
Efficiency of the ethnodirected approach
With respect to the search for new drugs, some studies have 
compared ethnodirected to other approaches, the random 
approach in particular, which consists of randomly collecting 
plants for phytochemical and pharmacological screening 
(Balick and Cox, 1996; Khafagi and Dewedar, 2000; Oliveira 
et al., 2011; Slish et al., 1999; see also Cragg and Newman, 
2003; 2005). In several instances the results of ethnodirected 
investigation are best compared to a random search for plants 
for specific therapeutic purposes. Khafagi and Dewedar (2000) 
investigated plants with antimicrobial activity that grow 
spontaneously in Sinai (Egypt) and found that 83% of the 
plants selected using the ethnodirected approach elicited such 
properties, while only 42% of the randomly selected plants did. 
Similarly, Slish et al. (1999) found that four out of 31 plants 
selected in Belize using the ethnobotanical approach exhibited 
vascular smooth muscle relaxant activity, while none among 
the 32 randomly collected ones exhibited this property.  
However, the interpretation of the results might lead to 
divergent conclusions on the efficiency of the ethnodirected 
approach as an indicator of promising plants. For instance, 
Khafagi and Dewedar (2000) found that the random approach 
led to the identification of a larger percentage of species 
with strong antimicrobial activity (13.9% versus 8.3%) 
even though the ethnobotanical approach allowed for the 
identification of a larger number of plants with antimicrobial 
activity. Thus, one of the lessons we could draw from this 
example is that, in some cases, finding a small number of 
plants that exhibit a property of interest to a high degree 
might be more relevant than finding a larger number of 
plants with lower levels of activity. Therefore, even in cases 
in which the ethnopharmacological approach seems to 
stand out, our enthusiasm might lead us to reach unsound 
conclusions regarding its actual relevance for the search of 
new drugs. Case et al. (2006) reported on the limitations of the 
ethnopharmacological approach in their study on drugs used 
for the treatment of respiratory diseases in Manus province, 
New Guinea. These authors selected the informant consensus 
model to identify the plants with potential pharmacological 
activity, but found that their underlying assumptions were 
inadequate to predict antimycobacterial activity. Hence, they 
warn that ethnodirected approaches should be considered 
limited while wider-scoped studies are needed to elucidate 
their relevance or incompatibility. 
Although the results from an ethnodirected approach will 
overlap with those of a random approach, studies indicate 
that there is no full agreement between the two methods in 
some cases. Examples can be found in the search for novel 
anticancer agents. Spjut (2005) reported that active species 
were detected more frequently (1.4- to 2.6-fold greater rate) 
from the group of medicinal and poisonous plants in relation 
to a plant species screened at random. Gyllenhaal et al. (2012) 
found that for many cancer cell lines, the random approach 
returned better results than the ethnomedical selection 
approach; as occurred with MCF-7 (human breast cancer) for 
which the random approach success rate was higher than the 
ethnomedical. The authors relativize their findings by arguing 
that the results could be due to the much higher sampling for 
random collections. However, according to the authors: 
“The overall analysis suggests that plants collected based on 
ethnomedical use may in fact have a somewhat higher rate of 
positive bioassays on a per-species or per sample basis, although 
a portion of these assay results may be due to ubiquitous bioactive 
compounds. Ethnomedical collections in general may nevertheless 
play a useful role in drug discovery programs due to this elevated 
rate of bioactivity”.
In the last two decades, few significant discoveries have 
been made in the field of ethnopharmacology (Gertsch, 2009). 
Some candidate compounds identified by the bioprospecting 
research-based ethnomedical approach, as developed by 
Shaman Pharmaceuticals, have failed, which leads to the 
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suggestion that an ethnodirected approach is not feasible for the 
development of novel drugs (Clapp and Crook, 2002). By contrast, 
the random approach has made effective contributions to the 
development of drugs, many of which are still available for the 
treatment of various diseases. One example is the search for new 
anticancer drugs conducted by the National Cancer Institute 
(NCI) of the United States. They employed the random approach 
in a program developed in the 1960s, resulting in several agents 
of clinical relevance such as “taxanes and camptothecins, but their 
development into clinically active agents spanned a period of some 
30 years, from the early 1960s to the 1990s” (Cragg and Newman, 
2005). Between 1960 and 1982 the NCI investigated about 35,000 
plants before the program was suspended (Beutler et al., 2012). 
According to Cragg and Newman (2005): 
“This plant collection program was terminated in 1982, but the 
development of new screening technologies led to the revival of 
collections of plants and other organisms in 1986, with a focus on 
the tropical and sub-tropical regions of the world”.
The examples described above raise a question: why 
do scientists still assert so strongly the benefits of the 
ethnodirected approach versus the random one when its 
application in practice does not lead to significant advances 
in the development of particular drugs? Why do they keep 
on conducting studies aimed at making lists of species and 
therapeutic indications? We cannot give definite answers to 
these questions but we hypothesize that the ethnodirected 
approach is perhaps only useful for particular types of diseases. 
Only well-conducted and rigorous ethnopharmacological/
ethnobotanical studies might clarify these issues. 
Influence of sampling and informant selection 
Ethnodirected studies of medicinal plants quite often exhibit 
sampling problems causing bias in their results. During the 
review of studies conducted in Brazil, Medeiros (2012) found 
that most of them had patent sampling flaws, the most 
frequent being the following: 1. lack of information on the 
universe (U) or sample (N) on which the survey of the human 
communities was grounded; and 2. lack of information on the 
U or N of a specific group (e.g., folk healers), in intentional 
samples based on specialists from the studied communities.  
Therefore, studies seeking to investigate the knowledge 
possessed by “local specialists” (e.g., folk healers) must 
establish with full certainty that they are truly dealing with 
such. Contrariwise, when there are no well-defined criteria 
for intentional selection the results might not reflect the 
investigators’ desires. Similarly, studies that rely on the 
informants’ consensus as an indicator of the most significant 
or popular species must take care to ensure an appropriate 
application of that model and select truly representative 
samples of the community. Conversely, non-representative 
samples might point certain plants as the most popular or 
versatile therapeutic indications when they are actually not. 
In addition, many studies have shown that the local 
knowledge on medicinal plants is not homogeneous, but rather 
it varies among the actors of a local community according 
to their age, gender, income, social role and intra-cultural 
acculturation differences (Voeks and Leony, 2004; Voeks, 2007; 
Camou-Guerrero et al., 2008). In such cases, the social actors 
who provide us information ought to be accurately identified 
to increase the success of selecting plants for bioprospecting 
purposes. For instance, investigators who focus on gender and 
age tend to emphasize the role of women and elders because 
they are considered to possess greater knowledge on medicinal 
plants. According to such authors, the reason that women 
possess such knowledge is attributed to their role in home 
and family care, and in the case of the elderly the reason is 
attributed to their longer interaction with the environment 
(Begossi et al., 2002; Voeks and Leony, 2004; Silva et al., 2011). 
Such patterns must not be misinterpreted and then be used 
as criteria for informant selection in later studies. Indeed, 
some authors have shown that the “stock of knowledge” of 
individuals from different age ranges might differ and that the 
knowledge of older individuals might actually be in decline 
(Silva et al., 2011). As a consequence, the assumption that older 
individuals are systematically better “informants” for studies 
of medicinal plants might be mistaken because people appear 
to employ different repertoires of medicinal plants according 
to their age. 
As regards to gender, some studies, such as the one 
conducted by Voeks and Leony (2004) in Brazilian rural 
communities, have emphasized the role of women because 
they are considered to possess greater knowledge of medicinal 
resources compared with men. However, other studies, such 
as the ones by Giraldi and Hanazaki (2010) and Poderoso et 
al. (2012), conducted in communities in Southeastern Brazil, 
have shown that such differences might not occur. Authors 
who have found differences suggest that they are associated 
with the role women play as homemakers, which place them 
in charge of the family’s basic healthcare, while men focus on 
other activities. 
Based on the roles the various social actors play and 
their knowledge of health care, we formulated the following 
suggestions for sample selection to optimize bioprospecting 
strategies: 1. Researchers should clearly establish  the goals 
they aim to attain, e.g., “Do I want to study one single and well-
defined therapeutic activity, or the full range of knowledge of the 
local medical system?”; 2. Consideration of age, gender and social 
function of individuals particular relevance in the selection 
of the informants who might effectively supply the expected 
information; and 3. Although  thorough knowledge of the 
existing international literature on the subject is necessary 
to give support to the study design, investigators should be 
careful not to restrict the sample as previous patterns detected 
in the literature. At times, time and financial restrictions 
induce us to look for faster strategies without taking into 
consideration that such behavior might impair the power of 
inference for the data. 
Searching for the most popular plants as a 
bioprospecting tool
Most ethnodirected studies identify the plants mentioned 
by the largest number of individuals, the most versatile 
plants (the ones with many potential therapeutic uses), or 
a combination of both criteria as the most interesting for 
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bioprospecting purposes. The ethnobiological literature 
describes a wide variety of quantitative indicators to establish 
such indications (Medeiros et al., 2011), which are often used; 
however, awareness of their limitations is appropriate. The 
first criterion has proven to be inadequate in some studies 
seeking to confirm the pharmacological activity of certain 
plants based on the traditional knowledge, as in the above-
mentionedstudy by Case et al. (2006). The authors used the 
informants’ consensus to select species from New Guinea 
of potential pharmacological interest for the treatment of 
respiratory diseases; however, they did not find such activity 
in the plants with highest levels of consensus. Many of the 
quantitative indicators suggested by the scientific literature 
were proposed with the purpose of revealing plants important 
for a given culture. The authors that applied those indices 
to indicate potential species for bioprospecting efforts were 
based on the idea that a plant relevant for a culture, with 
great cultural consensus is more likely to present biological 
activities. Furthermore, most of these indices do not consider 
the particularities of the plants used in mixtures.
The expectation in the use of the above-mentioned criteria 
is usually to obtain the same lists of plants as reported in 
previous studies, oftenly highly popular exotic or native plants 
with wide local distribution. For that reason, paying attention 
to plants that are mentioned less frequently might be relevant 
for bioprospecting because low popularity is not a synonym 
for lack of efficacy. The high presence and importance of a 
plant in a local medical system is not necessarily linked to its 
pharmacological effect, but can be due several other factors. 
Moerman (2007) discusses that a plant used for treatment 
can be widespread in a community and may not contain 
any biologically active compounds. Instead, the symbolic 
meaning of the treatment within the culture can alter the 
patient’s physiology, acting similar to a “placebo,” and appears 
effective because of the cultural validation and the local belief 
in its effectiveness. In addition, ecological factors, such as 
environmental and seasonal availability, can influence the 
importance of medicinal plants. For example, Molares and 
Ladio (2009) mentioned that species located geographically 
closer to a community may be used more oftenly, imparting 
greater importance to this group of plants.
The data on less popular plants, inadequately disseminated 
within a social group for several reasons, might provide 
valuable information for bioprospecting strategies. For 
instance, Reyes-García et al. (2008) observed that the low 
prestige of a given community member providing observations 
about plant species might directly interfere with the reception 
and cultural acceptance of that information by other 
community members. As a consequence, the dissemination of 
some information might remain restricted due to of forces that 
hinder its circulation (e.g., family secrets) or block its reception 
(e.g., low prestige of the information source).
On this view, such plants might be rarely mentioned for 
reasons like: a, the plant might have recently entered the 
local medical system (recent introduction); b, the plant is 
being excluded from the local medical system; c, the plant 
is indicated for the treatment of diseases affecting specific 
social actors (e.g., age- or gender-specific diseases) and thus, 
it is not known by the overall population; d, the popularity 
of the plant in the local medical system might have always 
been low (restricted to a few families or individuals); or e, the 
low availability or the difficulty in accessing the plant in the 
environment. 
As a result, rarely mentioned plants might actually be 
highly valuable from the bioprospecting perspective because 
they bear the additional advantage of being less well-studied 
and could serve as the basis for further systematic quests for 
medicinal products. There is a necessity to test differences 
in the pharmacological activity between the most and least 
popular plants.  
Problems related to data collection and recording 
therapeutic indications
At times, testing of the biological activity of medicinal plants 
based on ethnodirected data is hindered by the lack of detail of 
the information gathered from local communities. Superficial 
data collection and interpretation is a serious mistake that 
one finds reproduced in many published studies. The lack of 
attention usually paid to therapeutic indications is noteworthy 
because it has a negative impact on the success of approaches 
requiring accurate and precise information. Many studies do 
not distinguish among the plants that serve to cure a disease, 
the ones that relieve its symptoms, and the ones that are 
able to prevent its occurrence. That distinction, however, has 
paramount importance in bioprospecting and thus should 
receive more attention.  
Some studies have demonstrated the relevance of 
investigating the concept of disease held by the community 
(Beiersmann et al., 2007; Reyes-García, 2010). The choice of 
therapies by human groups is related to how they recognize 
and classify diseases (Reyes-García, 2010), so an accurate 
understanding of those features is key for the planning of 
future bioprospecting strategies. One simple method to 
investigate the local perception of a given disease is to ask the 
informants how it is recognized. This strategy identifies the 
symptoms that are directly associated with the disease. For 
instance, the activity of a plant mentioned in the treatment 
of various diseases mainly associated with the symptom pain 
might reduce the release of chemical mediators related to the 
production of pain. 
More than a few studies have merely recorded the medicinal 
properties of plants without investigating the local notions of 
disease, which might be widely divergent from Western ideas. 
This situation is illustrated by the study by Ferreira Júnior et 
al. (2011), which investigated the plants from the Brazilian 
Caatinga used to treat inflammation. Although inflammation 
is considered as uniform in the ethnobotanical literature, the 
authors recorded 37 different categories of that condition as 
perceived by the community, and characterized it as a result 
of 26 different symptoms. Interestingly, the plants used 
for the treatment of the various categories exhibited broad 
differences, thus showing that inflammation could not be 
considered a homogeneous “category” and that the studies 
might be strongly biased. Ferreira Júnior et al. (2011) also found 
that some conditions identified as “inflammation” by the 
investigated community were not thus understood in Western 
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conventional medicine. That finding makes the elucidation of 
local notions of disease even more relevant. Similarly, Oliveira 
et al. (2011) paid attention to local notions of disease. While 
investigating the plants used by Quilombola communities 
in the state of Pará (Northern Brazil) for the treatment of 
respiratory diseases, the authors found that tuberculosis was 
called “enfeeblement” and so the identification of the local 
notions had direct implications for ethnodirected studies. 
Beiersmann et al. (2007) studied the plants used to treat 
malaria in seven villages in Burkina Faso and identified four 
variations of disease, each one having its particular treatment, 
including the use of plants and/or conventional Western 
therapies. This finding further showed that studies that do not 
include a thorough understanding of the diseases mentioned 
by a given human group are at risk of collecting biased data 
and of using the ethnodirected information incorrectly. In this 
case, the researcher took notice of these differences and as a 
result errors were minimized in the process of noting points 
of convergence and divergence between local and biomedical 
systems.
The procedures for collecting data on the medicinal plants 
at a given site might exert a strong influence on the success of 
pharmacological studies. The informants might apply several 
criteria to the indication or use of a given species for medicinal 
purposes, including a variable that is often omitted in studies, 
the local perception of the efficacy of treatment (Ferreira Júnior 
et al., 2011; 2012). The latter might supply valuable hints for 
bioprospecting purposes because certain species might be 
preferentially reported as a function of their perceived efficacy. 
Therefore, the investigations of these species increase the 
odds of success in future studies. In addition, it is also worth 
investigating the informants’ notion of the efficacious use of 
a plant for a given purpose (Etkin, 1988).
It must be considered that the issues we pointed out 
regarding the misinterpretation of the concepts of illnesses in 
other cultures happen mostly on societies whose knowledge 
has not still been decoded. One of the reviewers of this article 
left us the following reflection: 
“In some codified traditional medicine system like Ayurveda and 
Unani, many of the traditional disease terms have been mapped to 
western medicine concept. Concepts and symptomology associated 
with the Traditional Chinese Medicine have already been started 
incorporating in the WHO’s ICD versions.”
Final considerations
We sought to call the attention to some of the weak points 
in ethnodirected approaches that might be overcome in the 
design of studies and interpretation of data. As a rule, the 
collection of ethnobotanical and ethnopharmacological data 
demands appropriate training and sound knowledge of the 
international literature from investigators of theoretical 
and methodological contributions to this field. Although 
significant methodological manuals, including those by Martin 
(1995) Alexiades (1996) and more recently by Albuquerque 
et al. (2010; 2014), and some important critical reviews (e.g., 
Gertsch, 2009; Heirinch et al., 2009), they do not appear to have 
exerted much influence on the quality of the published studies 
(Albuquerque, 2013) on recent years. Therefore, a major lesson 
to be learned from the discussion above is that researchers 
must reconsider projects aiming at a mere elaboration of 
lists of species and their therapeutic indications. Such lists, 
and the various sources of bias they include, are increasingly 
showing their lack of relevance for bioprospecting purposes. 
The limitations pointed out in this study are not inherent to 
ethnopharmacological research, but rather happen due to the 
lack of knowledge on the chosen tools. Every single scientific 
method has limitations, which leaves the researchers the 
responsibility for applying theoretical and practical knowledge 
to make the most appropriate choices, as well as to draw 
pertinent conclusions 
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